Trochanteric Bursitis
7
0
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
The HIP Self-management Study
LEAP-Ireland Feasibility Trial of Exercise and Education for Gluteal Tendinopathy
Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis
Dry Needling and Lateral Hip Pain (GTPS)
Core Resistance and Lateral Hip Pain
Percutaneous Ultrasonic Tenotomy Versus Platelet Rich Plasma for Gluteal Tendinopathy
Comparison of Ozone and Steroid Injection in Patients With Greater Trochanteric Pain Syndrome